Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0846-2025Class II

Stryker Blueprint Mixed Reality BP MxR Glenoid Pin Guide, REF MRUE200. Indicated for use during Total...

Tornier S.A.S. / initiated 2024-12-18 / Open, Classified / root cause: design

Tornier S.A.S. began a recall of Stryker Blueprint Mixed Reality BP MxR Glenoid Pin Guide, REF MRUE200. Indicated for use during Total Shoulder Arthroplasty on . FDA classified it as Class II and gives the reason as "The Pin Guide is being recalled because the metal tube may disassemble from the plastic handle. This can result in the Blueprint Mixed Reality headset being unable to detect the Pin Guide and potentially prolonging...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as design.

Recall record

Recall number
Z-0846-2025
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Tornier S.A.S.
Product
Stryker Blueprint Mixed Reality BP MxR Glenoid Pin Guide, REF MRUE200. Indicated for use during Total Shoulder Arthroplasty.
Product code
OLO Orthopedic Stereotaxic Instrument
Reason for recall
The Pin Guide is being recalled because the metal tube may disassemble from the plastic handle. This can result in the Blueprint Mixed Reality headset being unable to detect the Pin Guide and potentially prolonging surgery time or changing of surgical method from guided to conventional.
Root cause tag
design
FDA root cause
Device Design
Action
Stryker issued an URGENT: MEDICAL DEVICE RECALL to its consignees on 12/18/2024 via email. The notice explained the problem with the device and requested the following actions be taken: "1. Review the product issue as communicated in this Recall Notice & communicate the issue as appropriate in your organization. 2. Locate and isolate/quarantine the affected device to prevent accidental use pending return. 3. Please use a device from a conforming lot for all procedures. 4. Return the enclosed business reply form by email to confirm receipt of this notification. a. Response is required, even if you may not have any physical inventory on site anymore. It may be that you no longer have any physical inventory on site. Completing this form will allow us to update our records and will also negate the need for us to send any further unnecessary communications on this matter. Therefore, please complete even if you no longer have any of the subject devices in your physical inventory. 5. Please ensure that all potential users of these products within your facility are made aware of this notification 6. Please complete the attached response form and return it to [email protected] so we may arrange for the return of the affected unit(s). 7. Maintain awareness of this communication internally until all required actions have been completed within your facility." Actions for distributors are as follows: "8. If you have further distributed the affected product, please notify your customers at once about this recall. You may copy and distribute this notification letter. a. If possible, inform us if any of the subject devices have been distributed to other organizations, including contact details so that we can inform the recipients appropriately. b. If you are a distributor, note that you are responsible for notifying your affected customers. 9. Please inform us of any adverse event and/or report them to the Health/Competent Authorities in accordance with c
Quantity in commerce
24 units
Distribution
US: MN, KY, MD, MA, TX, AK, TX, ID; France, Canada
Product codes and lots
UDI/DI 03700434022926, Lot Numbers: 22A796, 22A797, 22A978, and 22A979

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0846-2025
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0846-2025Class IIOngoingVoluntary: Firm initiated